Results 111 to 120 of about 14,159 (238)

Current Evidences and Future Perspectives in the Management of Metastatic Non‐Clear Cell Renal Cell Carcinoma

International Journal of Urology, EarlyView.
ABSTRACT Renal cell carcinoma is a heterogeneous disease with diverse phenotypes. Renal cell carcinoma classification is based on morphological and molecular characteristics and falls into 2 main categories: clear cell renal cell carcinoma and non‐clear cell renal cell carcinoma.
Shotaro Nakanishi, Junichi Inokuchi
wiley   +1 more source

Efficacy of Sunitinib and Sorafenib in Metastatic Papillary and Chromophobe Renal Cell Carcinoma [PDF]

, 2007
Toni K. Choueiri, A. Plantade, Paul Elson, Sylvie Négrier, Alain Ravaud, Stéphane Oudard, Ming Zhou, Brian I. Rini, Ronald M. Bukowski, Bernard Escudier   +9 more
openalex   +1 more source

Clinicopathological Characteristics of Upper Tract Urothelial Cancer With Loss of Immunohistochemical Expression of Mismatch Repair Proteins

International Journal of Urology, EarlyView.
ABSTRACT Objectives Lynch syndrome (LS) is an inherited cancer predisposition caused by germline mutations in DNA mismatch repair (MMR) genes. Upper tract urothelial carcinoma (UTUC) is the third most common cancer associated with LS. In this study, we examined MMR protein expression in UTUC using immunohistochemistry to clarify the clinicopathological
Go Kobayashi, Tetsutaro Hayashi, Yohei Sekino, Kenichiro Ikeda, Hikaru Nakahara, Kohei Kobatake, Keisuke Goto, Daiki Taniyama, Kazuya Kuraoka, Shintaro Akabane, Hiroaki Niitsu, Takao Hinoi, Kazuhiro Sentani, Nobuyuki Hinata   +13 more
wiley   +1 more source

Chromophobe Renal Cell Carcinoma.

Online Journal of Health & Allied Sciences, 2013
Renal cell carcinoma is the most common neoplasm of the kidney comprised of different histological variants. Chromophobe renal cell carcinoma (ChRCC) is a rare subtype of renal cell carcinoma (RCC) mainly diagnosed in the sixth decade of life.
Jyotsna Vijaykumar Wader, Sujata S Kumbhar, Huddedar AD, Wasim GM Khatib   +3 more
doaj  

Immunoexpression of TTF-1 in Non-Lung Tumors

Bezmiâlem Science, 2014
Objective:Thyroid transcription factor-1 (TTF-1) immunoexpression is frequently determined in small-cell lung carcinomas, as well as primary lung adenocarcinomas. While dealing with metastatic carcinomas, TTF-1 immunoexpression is a significant indicator
Zeynep TOSUNER, Dilek Sema ARICI, Zühal GÜCİN, Nur BÜYÜKPINARBAŞILI, Fatma Cavide SÖNMEZ, Pelin YILDIZ   +5 more
doaj   +1 more source

Surgical Outcomes of the Non‐renorrhaphy Technique During Robot‐Assisted Partial Nephrectomy for Highly Complex Renal Tumors (RENAL Score ≥ 10)

International Journal of Urology, EarlyView.
ABSTRACT Objectives Non‐renorrhaphy technique during partial nephrectomy has not been sufficiently studied. This study aimed to evaluate the surgical outcomes of the non‐renorrhaphy technique in robot‐assisted partial nephrectomy (RAPN) for tumors with RENAL scores of 10–12. Methods We retrospectively analyzed 51 consecutive patients who underwent RAPN
Kosuke Hamada, Takeshi Yamasaki, Shoma Yamamoto, Taisuke Matsue, Nao Yukimatsu, Taiyo Otoshi, Minoru Kato, Katsuyuki Kuratsukuri, Junji Uchida   +8 more
wiley   +1 more source

Fragility fractures in well‐differentiated gastroenteropancreatic neuroendocrine tumors: Results from a multicentered retrospective study

Journal of Neuroendocrinology, EarlyView.
Abstract Patients with gastroenteropancreatic–neuroendocrine tumors (GEP‐NETs) may present skeletal fragility that might be related to multiple factors, including bone metastases, vitamin D deficiency, hormone secretion, and disease treatments. This study examines the prevalence and determinants of fragility fractures in low grading (G1‐G2) GEP‐NETs ...
Alessandro Brunetti, Miriam Cellini, Elisabetta Lavezzi, Alessandro Zerbi, Giuseppe Ferrillo, Maria Francesca Birtolo, Alfredo Berruti, Guido Cavati, Marta Lagana, Luigi Gennari, Rossano Girometti, Chiara Zuiani, Franco Grimaldi, Andrea G. Lania, Fabio Vescini, Gherardo Mazziotti   +15 more
wiley   +1 more source

Difference between RAT and clear cell papillary renal cell carcinoma/clear renal cell carcinoma [PDF]

, 2009
Michal Michal, Ondřej Hes, Naoto Kuroda, Dmitry V. Kazakov, Milan Hora   +4 more
openalex   +1 more source

Thyroid lesions of neuroendocrine origin? Thinking of a “polka‐dotted” zebra! Case series from three Italian referral centers and review of the literature

Journal of Neuroendocrinology, EarlyView.
Thyroid metastases from neuroendocrine neoplasm (NEN) should be considered in case of suspicious thyroid nodules in patients with a positive medical history of NEN, mainly of thoracic origin, even after many years from the initial diagnosis. The differential diagnosis from primary intrathyroidal NEN is challenging.
Tiziana Feola, Alessia Cozzolino, Federica Grillo, Maria Francesca Birtolo, Irene Aini, Erika Messina, Roberto Minotta, Alessia Filice, Isabella Zanata, Paola Razzore, Manila Rubino, Andrea M. Isidori, Annamaria Colao, Antongiulio Faggiano, Elisa Giannetta, on behalf of NIKE group, Irene Aini, Manuela Albertelli, Ylenia Alessi, Simone Antonini, Luigi Barrea, Elio Benevento, Maria Francesca Birtolo, Federica Campolo, Celeste Cantone, Silvia Carra, Rob‐erta Centello, Alessia Cozzolino, Federica De Cicco, Valentina Di Vito, Beatrice Fazzalari, Stefano Gay, Elisa Giannetta, Federica Grillo, Elia Guadagno, Valentina Guarnotta, Iderina Hasballa, Alice Laffi, Andrea Lania, Alessia Liccardi, Rossella Mazzilli, Erika Messina, Roberto Minotta, Giovanna Muscogiuri, Carla Pandozzi, Gabriella Pugliese, Giulia Puliani, Alberto Ragni, Manila Rubino, Rosaria Maddalena Ruggeri, Franz Sesti, Maria Grazia Tarsitano, Ludovica Verde, Giovanni Vitale, Virginia Zamponi, Isabella Zanata, Roberta Modica, Giuseppe Fanciulli, Anna La Salvia, Erika Maria Grossrubatscher, Francesco Ferrau, Alessandro Veresani, Flaminia Russo   +62 more
wiley   +1 more source

Identification of PANoptosis-related signature reveals immune infiltration characteristics and immunotherapy responses for renal cell carcinoma

BMC Cancer
PANoptosis is a specific type of inflammatory programmed cell death (PCD) modality that can be involved in three key modes of cellular programmed cell death-pyroptosis, apoptosis and necroptosis. We analyzed PANoptosis activity in three common renal cell
Yan Xu, Jingqi Hua, Hongliang Que, Tengyue Zeng, Quan Li, Junpeng Deng, Jianjun Xie   +6 more
doaj   +1 more source